semaglutide family BMI & the Role of

Novo Nordisks semaglutide is expected to lose its patent protection in Canada, Brazil, India, and China in 20252026

2015;40(10)(Diabetes suppl):8-11

GLP-1 is responsible for: Stimulating insulin production, which pulls sugar from the blood and carries it to the cells to be used as energy Regulating the appetite and hunger signals Decreasing the release of glucagon to lower blood sugar Controlling the rate at which the stomach empties after eating Medications like Semaglutide perform the same functions as GLP-1

Do not use the tablets after the expiry date printed on the pack even if they look unchanged, the coating integrity may be compromised

3.3% increase in the low-fat group) [211]

Similar content being viewed by others Introduction Type 1 diabetes (T1DM), prevalent in 5 to 10% of the diabetic population, is a result of the immune-mediated destruction of pancreatic beta cells